Coral Laboratories Limited (CORALAB.BO)
INR 688.65
(3.22%)
INR 688.65
(3.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 227.07 Million INR | 51.67% |
| 2022 | 107.44 Million INR | -17.82% |
| 2021 | 139.87 Million INR | -33.6% |
| 2020 | 198.56 Million INR | 75.45% |
| 2019 | 112.93 Million INR | -35.85% |
| 2018 | 175.76 Million INR | -11.26% |
| 2017 | 198.12 Million INR | -25.96% |
| 2016 | 263.16 Million INR | 38.08% |
| 2015 | 193.64 Million INR | 29.85% |
| 2014 | 149.25 Million INR | 31.99% |
| 2013 | 112.99 Million INR | 48.41% |
| 2012 | 75.53 Million INR | 0.7% |
| 2011 | 75.01 Million INR | 13.46% |
| 2010 | 66.11 Million INR | -10.64% |
| 2009 | 73.98 Million INR | 18.73% |
| 2008 | 62.31 Million INR | 15.0% |
| 2007 | 54.18 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 107.35 Million INR | 49.09% |
| 2023 Q4 | 62.46 Million INR | 197.37% |
| 2023 Q3 | 21 Million INR | -73.61% |
| 2023 FY | - INR | 51.67% |
| 2023 Q1 | 30.31 Million INR | 428.15% |
| 2023 Q2 | 79.6 Million INR | 162.57% |
| 2022 Q1 | 27.58 Million INR | -22.09% |
| 2022 Q2 | 65.24 Million INR | 136.54% |
| 2022 Q3 | 23.48 Million INR | -64.01% |
| 2022 FY | - INR | -17.82% |
| 2022 Q4 | -9.23 Million INR | -139.35% |
| 2021 Q4 | 35.4 Million INR | 315.11% |
| 2021 Q1 | 77.48 Million INR | 82.89% |
| 2021 Q2 | 18.46 Million INR | -76.17% |
| 2021 Q3 | 8.52 Million INR | -53.81% |
| 2021 FY | - INR | -33.6% |
| 2020 Q1 | 62.44 Million INR | 18.86% |
| 2020 FY | - INR | 75.45% |
| 2020 Q4 | 42.36 Million INR | -22.54% |
| 2020 Q3 | 54.69 Million INR | 48.32% |
| 2020 Q2 | 36.87 Million INR | -40.95% |
| 2019 Q1 | 10.09 Million INR | 313.17% |
| 2019 Q2 | 17.24 Million INR | 70.82% |
| 2019 FY | - INR | -35.85% |
| 2019 Q3 | 31.93 Million INR | 85.14% |
| 2019 Q4 | 52.53 Million INR | 64.52% |
| 2018 Q2 | 77.38 Million INR | 39.5% |
| 2018 FY | - INR | -11.26% |
| 2018 Q4 | -4.73 Million INR | -110.25% |
| 2018 Q3 | 46.2 Million INR | -40.29% |
| 2018 Q1 | 55.46 Million INR | 7.63% |
| 2017 Q4 | 51.53 Million INR | 66.97% |
| 2017 FY | - INR | -25.96% |
| 2017 Q1 | 33.26 Million INR | -49.79% |
| 2017 Q2 | 80.76 Million INR | 142.81% |
| 2017 Q3 | 30.86 Million INR | -61.78% |
| 2016 Q1 | 50.61 Million INR | -9.8% |
| 2016 FY | - INR | 38.08% |
| 2016 Q3 | 82.23 Million INR | 25.22% |
| 2016 Q4 | 66.25 Million INR | -19.43% |
| 2016 Q2 | 65.67 Million INR | 29.76% |
| 2015 FY | - INR | 29.85% |
| 2015 Q4 | 56.1 Million INR | 0.99% |
| 2015 Q3 | 55.55 Million INR | 36.32% |
| 2015 Q1 | 39.73 Million INR | -19.95% |
| 2015 Q2 | 40.75 Million INR | 2.57% |
| 2014 Q2 | 36.56 Million INR | 64.16% |
| 2014 Q1 | 22.27 Million INR | 47.37% |
| 2014 FY | - INR | 31.99% |
| 2014 Q4 | 49.63 Million INR | 25.7% |
| 2014 Q3 | 39.48 Million INR | 7.98% |
| 2013 FY | - INR | 48.41% |
| 2013 Q2 | 30.85 Million INR | 8.99% |
| 2013 Q4 | 15.11 Million INR | -41.59% |
| 2013 Q3 | 25.87 Million INR | -16.12% |
| 2013 Q1 | 28.3 Million INR | 112.8% |
| 2012 Q3 | 19.11 Million INR | -6.74% |
| 2012 Q1 | 22.8 Million INR | 11.6% |
| 2012 Q2 | 20.49 Million INR | -10.12% |
| 2012 Q4 | 13.3 Million INR | -30.39% |
| 2012 FY | - INR | 0.7% |
| 2011 Q1 | 21.73 Million INR | 890.99% |
| 2011 Q4 | 20.42 Million INR | -15.01% |
| 2011 Q3 | 24.03 Million INR | 36.22% |
| 2011 Q2 | 17.64 Million INR | -18.8% |
| 2011 FY | - INR | 13.46% |
| 2010 Q3 | 15.45 Million INR | -43.77% |
| 2010 Q1 | 23.77 Million INR | 0.0% |
| 2010 FY | - INR | -10.64% |
| 2010 Q2 | 27.49 Million INR | 15.61% |
| 2010 Q4 | -2.74 Million INR | -117.77% |
| 2009 FY | - INR | 18.73% |
| 2008 FY | - INR | 15.0% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | -150.464% |
| Bacil Pharma Limited | -569.32 Thousand INR | 39985.477% |
| BDH Industries Limited | 124.27 Million INR | -82.724% |
| Beryl Drugs Limited | 26.63 Million INR | -752.419% |
| Cian Healthcare Limited | 122.56 Million INR | -85.267% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -1274.718% |
| Deccan Health Care Limited | 37.5 Million INR | -505.439% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 8448.382% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -174.86% |
| Concord Drugs Limited | 40.52 Million INR | -460.405% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -1330.22% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 72.674% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -35449.836% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -1810.128% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 39.905% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -1860.256% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 62.802% |
| Makers Laboratories Limited | 25.81 Million INR | -779.73% |
| Medi-Caps Limited | 4.77 Million INR | -4659.505% |
| MedPlus Health Services Limited | 3.94 Billion INR | 94.238% |
| Panchsheel Organics Limited | 189.36 Million INR | -19.913% |
| Parmax Pharma Limited | 22.93 Million INR | -889.978% |
| Parnax Lab Limited | 243.59 Million INR | 6.783% |
| Patidar Buildcon Limited | -5.52 Million INR | 4209.229% |
| Phaarmasia Limited | -1.58 Million INR | 14453.729% |
| PRAVEG LIMITED | 321.43 Million INR | 29.356% |
| Sunil Healthcare Limited | 93.07 Million INR | -143.961% |
| Syschem (India) Limited | 70.4 Million INR | -222.547% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -159.271% |
| Sastasundar Ventures Limited | -203.51 Million INR | 211.578% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 56030.049% |
| Smruthi Organics Limited | 120.31 Million INR | -88.739% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -406.821% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 10.661% |
| Trident Lifeline Limited | 102.69 Million INR | -121.121% |
| Transchem Limited | 56.61 Million INR | -301.116% |
| Trinity League India Limited | -26.25 Million INR | 964.953% |
| Tyche Industries Limited | 128.2 Million INR | -77.117% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 41.312% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 801.306% |
| Vivanza Biosciences Limited | 11.2 Million INR | -1926.74% |
| Zenith Healthcare Limited | 4.98 Million INR | -4452.446% |
| Zenlabs Ethica Limited | 27.09 Million INR | -738.043% |
| Mercury Laboratories Limited | 101.18 Million INR | -124.41% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -155.113% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -169.603% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 250.329% |
| Roopa Industries Limited | 55.7 Million INR | -307.67% |
| PANJON LTD. | 4.08 Million INR | -5453.338% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 284.192% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 1291.875% |
| Anuh Pharma Limited | 878.5 Million INR | 74.152% |
| Crestchem Limited | 30.33 Million INR | -648.578% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 2199.057% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -735.053% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 41.623% |
| Trimurthi Limited | -2.47 Million INR | 9261.795% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | -4.839% |
| Norris Medicines Limited | -1.78 Million INR | 12827.441% |
| Veerhealth Care Limited | 15.99 Million INR | -1319.669% |
| Lactose (India) Limited | 201.22 Million INR | -12.848% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 336.117% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | -33.126% |
| Gennex Laboratories Limited | 219.35 Million INR | -3.519% |
| Denis Chem Lab Limited | 224.84 Million INR | -0.991% |
| Colinz Laboratories Limited | 5.42 Million INR | -4083.419% |
| Godavari Drugs Limited | 134.62 Million INR | -68.673% |
| Zenotech Laboratories Limited | 172.64 Million INR | -31.528% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 49.401% |
| Bharat Parenterals Limited | 265.74 Million INR | 14.55% |
| Evoq Remedies Limited | 6.18 Million INR | -3569.633% |
| Kerala Ayurveda Limited | 70.78 Million INR | -220.788% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 2748.734% |
| Natural Capsules Limited | 219.9 Million INR | -3.263% |
| Auro Laboratories Limited | 121.73 Million INR | -86.532% |